{"id":"https://openalex.org/W3045835002","doi":"https://doi.org/10.1007/s13300-020-00892-0","title":"Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog\u00ae in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis","display_name":"Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog\u00ae in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis","publication_year":2020,"publication_date":"2020-07-29","ids":{"openalex":"https://openalex.org/W3045835002","doi":"https://doi.org/10.1007/s13300-020-00892-0","mag":"3045835002","pmid":"https://pubmed.ncbi.nlm.nih.gov/32728832","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7435141"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-020-00892-0","doi":"https://doi.org/10.1007/s13300-020-00892-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-020-00892-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-020-00892-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-020-00892-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074615496","display_name":"Junnosuke Miura","orcid":"https://orcid.org/0000-0002-5115-1111","observed_orcids":["https://orcid.org/0000-0002-5115-1111"]},"institutions":[{"id":"https://openalex.org/I4210136522","display_name":"Tokyo Women's Medical University","ror":"https://ror.org/03kjjhe36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210136522"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junnosuke Miura","raw_affiliation_strings":["Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan","institution_ids":["https://openalex.org/I4210136522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076145238","display_name":"Makoto Imori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Makoto Imori","raw_affiliation_strings":["Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan. imori_makoto@lilly.com","Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan. imori_makoto@lilly.com","institution_ids":["https://openalex.org/I4210108315"]},{"raw_affiliation_string":"Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065805983","display_name":"Hiroshi Nishiyama","orcid":"https://orcid.org/0000-0001-5034-5777","observed_orcids":["https://orcid.org/0000-0001-5034-5777"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Nishiyama","raw_affiliation_strings":["Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082595973","display_name":"Takeshi Imaoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Imaoka","raw_affiliation_strings":["Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., 5-1-28, Isogami-dori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan","institution_ids":["https://openalex.org/I4210108315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5076145238"],"corresponding_institution_ids":["https://openalex.org/I4210108315"],"apc_list":{"value":5899,"currency":"USD","value_usd":5899},"apc_paid":{"value":5899,"currency":"USD","value_usd":5899},"fwci":1.1308,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.78496014,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"11","issue":"9","first_page":"2089","last_page":"2104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":0.7710000276565552},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8859999775886536},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6919999718666077},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9049999713897705},{"id":"https://openalex.org/keywords/postprandial-glucose-excursions","display_name":"postprandial glucose excursions","score":0.9769999980926514},{"id":"https://openalex.org/keywords/mixed-meal-tolerance-test","display_name":"mixed meal tolerance test","score":0.9269999861717224},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6150000095367432},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.550000011920929},{"id":"https://openalex.org/keywords/insulin-analogs","display_name":"insulin analogues","score":0.3089999854564667},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5569999814033508},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.7360000014305115},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.3490000069141388},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3709999918937683},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.9232765436172485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8832018375396729},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7216857671737671},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5119815468788147},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.50861656665802},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5076714754104614},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5021216869354248},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4685284495353699},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.4194742441177368},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3010702133178711}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s13300-020-00892-0","doi":"https://doi.org/10.1007/s13300-020-00892-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-020-00892-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-020-00892-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7435141","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7435141","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmid:32728832","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32728832","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s13300-020-00892-0","doi":"https://doi.org/10.1007/s13300-020-00892-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-020-00892-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-020-00892-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6800000071525574,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320333624","display_name":"Eli Lilly Japan","ror":"https://ror.org/01sv7f575"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3045835002.pdf","grobid_xml":"https://content.openalex.org/works/W3045835002.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1555860740","https://openalex.org/W1896782898","https://openalex.org/W1934660672","https://openalex.org/W1965146429","https://openalex.org/W2003719947","https://openalex.org/W2007221722","https://openalex.org/W2027398852","https://openalex.org/W2076693232","https://openalex.org/W2090824142","https://openalex.org/W2110944104","https://openalex.org/W2112851047","https://openalex.org/W2113086214","https://openalex.org/W2115867446","https://openalex.org/W2129512027","https://openalex.org/W2134194392","https://openalex.org/W2191569664","https://openalex.org/W2234545288","https://openalex.org/W2404761572","https://openalex.org/W2470838351","https://openalex.org/W2550902579","https://openalex.org/W2753058356","https://openalex.org/W2808966396","https://openalex.org/W2886853964","https://openalex.org/W2915883495","https://openalex.org/W2948435545","https://openalex.org/W2982692300","https://openalex.org/W2996698293","https://openalex.org/W3005643088","https://openalex.org/W3031122959","https://openalex.org/W3035136981","https://openalex.org/W3165518450","https://openalex.org/W4239349741"],"related_works":["https://openalex.org/W3045982860","https://openalex.org/W3192708164","https://openalex.org/W3031122959","https://openalex.org/W3121741955","https://openalex.org/W3034473035","https://openalex.org/W4293013401","https://openalex.org/W2948999433","https://openalex.org/W4390816083","https://openalex.org/W3039681635","https://openalex.org/W4281663936"],"abstract_inverted_index":{"INTRODUCTION:":[0],"We":[1],"evaluated":[2],"the":[3,28,168,218],"efficacy":[4],"and":[5,77,85,98,100,112,158,190,213,248,295,300],"safety":[6],"of":[7,19,122,284,289],"ultra-rapid":[8],"lispro":[9,14,136,176],"(URLi)":[10],"in":[11,15,63,102,208,282,304],"comparison":[12,202],"to":[13,38,46,71,106,129,175,185,196,203,232,241,256,266,315],"a":[16,92],"subgroup":[17],"analysis":[18],"Japanese":[20,126,305],"adults":[21],"with":[22],"type":[23],"1":[24],"diabetes":[25],"mellitus":[26],"from":[27,67,104,125],"phase":[29],"3":[30],"PRONTO-T1D":[31],"trial.":[32],"METHODS:":[33],"After":[34],"an":[35],"8-week":[36],"lead-in":[37],"optimize":[39],"basal":[40],"insulin":[41],"treatment,":[42],"patients":[43,127],"were":[44,83,150,224,277],"randomized":[45,128],"52-week":[47],"double-blind":[48,130],"mealtime":[49,75,96,113,153,188,205],"URLi":[50,76,97,111,131,142,162,206,297,308],"or":[51,53,135,140,287],"lispro,":[52,99,157,204],"26-week":[54,123],"open-label":[55,141],"postmeal":[56,110,161,199,296],"URLi.":[57,200],"The":[58,79],"primary":[59],"endpoint":[60],"was":[61,177],"change":[62,101],"hemoglobin":[64],"A1c":[65],"(HbA1c)":[66],"baseline":[68,105,147],"(week":[69],"0)":[70],"week":[72,107,166,274],"26":[73,108],"between":[74,95,109],"lispro.":[78,114,316],"multiplicity":[80],"adjusted":[81],"objectives":[82],"1-":[84,212],"2-h":[86,214,270],"postprandial":[87],"glucose":[88],"(PPG)":[89],"excursions":[90,216,247,272],"after":[91],"meal":[93],"test":[94],"HbA1c":[103,148],"RESULTS:":[115],"This":[116],"manuscript":[117],"presents":[118],"pre-specified":[119],"exploratory":[120],"analyses":[121],"data":[124],"(n":[132,137,143],"=":[133,138,144],"62)":[134],"59),":[139],"46).":[145],"Mean":[146],"levels":[149],"7.52%":[151],"for":[152,156,160,187,198,244,269],"URLi,":[154,189],"7.44%":[155],"7.51%":[159],"at":[163,273],"randomization.":[164],"At":[165],"26,":[167],"least":[169],"squares":[170],"mean":[171],"(LSM)":[172],"difference":[173],"compared":[174,314],"0.04%":[178],"(95%":[179,192],"confidence":[180],"interval":[181],"[CI]":[182],"-":[183,194,225,230,239,242,249,254,257,264,267],"0.14":[184],"0.22)":[186],"0.16%":[191],"CI":[193,229,238,253,263],"0.04":[195],"0.35)":[197],"In":[201],"resulted":[207],"statistically":[209],"significantly":[210],"lower":[211],"PPG":[215,246,271,312],"during":[217],"mixed-meal":[219],"tolerance":[220],"test.":[221],"LSM":[222],"differences":[223,281],"40.5":[226],"mg/dL,":[227,251],"95%":[228,237,252,262],"59.5":[231],"21.4":[233],"(-":[234,259],"2.25":[235],"mmol/L,":[236,261],"3.3":[240],"1.2)":[243,268],"1-h":[245],"51.7":[250],"81.7":[255],"21.8":[258],"2.87":[260],"4.5":[265],"26.":[275],"There":[276],"no":[278],"significant":[279],"treatment":[280],"rates":[283],"severe/overall":[285],"hypoglycemia,":[286],"incidence":[288],"treatment-emergent":[290],"adverse":[291],"events.":[292],"CONCLUSIONS:":[293],"Mealtime":[294,307],"provide":[298],"effective":[299,311],"comparable":[301],"glycemic":[302],"control":[303,313],"patients.":[306],"demonstrated":[309],"more":[310],"TRIAL":[317],"REGISTRATION:":[318],"ClinicalTrials.gov,":[319],"NCT03214367.":[320]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2020-08-03T00:00:00"}